The effort required to achieve and maintain optimal glycemic control

Journal of Diabetes and its Complications

Volumn 25, Issue 5, 2011, Pages 283-288

  Rosenthal, Elyse S ^a   Bashan, Eran ^a   Herman, William H ^b   Hodish, Israel ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Dosage adjustment; Insulin

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; EVALUATION; FEMALE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN TREATMENT; MALE; MEAL; MEDICAL RECORD REVIEW; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

AGED; BLOOD GLUCOSE SELF-MONITORING; COHORT STUDIES; COST OF ILLNESS; DIABETES MELLITUS, TYPE 2; DRUG MONITORING; FEASIBILITY STUDIES; FEMALE; HEALTH CARE COSTS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; INSULIN, LONG-ACTING; INSULIN, SHORT-ACTING; MALE; MEDICATION ADHERENCE; MIDDLE AGED; TIME FACTORS;

EID: 80052700982     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2011.01.002     Document Type: Article

References (22)

1. American Diabetes Association (2009). Standards of medical care in diabetes - 2009 Diabetes Care 32 Suppl 1 2009 S13 S61
2. Bergenstal R.M., and Johnson M. Adjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine Diabetes Care 31 7 2008 1305 1310
3. Bretzel R.G., and Nuber U. Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial Lancet 371 9618 2008 1073 1084 (Pubitemid 351436611)
4. Buse J.B., and Wolffenbuttel B.H. DURAbility of basal versus lispro mix 75/25 insulin efficacy (DURABLE) trial 24-week results: safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes Diabetes Care 32 6 2009 1007 1013
5. DeVries J.H., and Snoek F.J. A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control Diabetes Care 25 11 2002 2074 2080
6. Doyle E.A., and Weinzimer S.A. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine Diabetes Care 27 7 2004 1554 1558 (Pubitemid 38857425)
7. Gerstein H.C., and Miller M.E. Effects of intensive glucose lowering in type 2 diabetes The New England Journal of Medicine 358 24 2008 2545 2559 (Pubitemid 351831356)
8. Heinemann L. Variability of insulin absorption and insulin action Diabetes Technology & Therapeutics 4 5 2002 673 682 (Pubitemid 35283332)
9. Herman W.H., and Ilag L.L. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes Diabetes Care 28 7 2005 1568 1573 (Pubitemid 40923066)
10. Hoerger T.J., and Segel J.E. Is glycemic control improving in U.S. adults? Diabetes Care 31 1 2008 81 86
11. Holman R.R., and Paul S.K. 10-year follow-up of intensive glucose control in type 2 diabetes The New England Journal of Medicine 359 15 2008 1577 1589
12. Holman R.R., and Thorne K.I. Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes The New England Journal of Medicine 357 17 2007 1716 1730 (Pubitemid 350005153)
13. Janka H.U., and Plewe G. Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes Diabetes Care 28 2 2005 254 259 (Pubitemid 40170922)
14. Kennedy L., and Herman W.H. Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial Diabetes Care 29 1 2006 1 8 (Pubitemid 44033422)
15. Koro C.E., and Bowlin S.J. Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report Diabetes Care 27 1 2004 17 20 (Pubitemid 38196703)
16. Levy J., and Atkinson A.B. Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study Diabetic Medicine 15 4 1998 290 296 (Pubitemid 28168508)
17. Shorr R.I., and Franse L.V. Glycemic control of older adults with type 2 diabetes: findings from the Third National Health and Nutrition Examination Survey, 1988-1994 Journal of the American Geriatrics Society 48 3 2000 264 267 (Pubitemid 30164208)
18. Stratton I.M., and Adler A.I. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ 321 7258 2000 405 412 (Pubitemid 30609442)
19. The Diabetes Control and Complications Trial Research Group (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus The New England Journal of Medicine 329 14 1993 977 986
20. The Writing Team for the Diabetes Control and Complications Trial (2002). Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus JAMA 287 19 2002 2563 2569
21. Tsui E., and Barnie A. Intensive insulin therapy with insulin lispro: a randomized trial of continuous subcutaneous insulin infusion versus multiple daily insulin injection Diabetes Care 24 10 2001 1722 1727 (Pubitemid 33716472)
22. Turner R.C., Cull C.A. UK Prospective Diabetes Study (UKPDS) Group Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49) JAMA 281 21 1999 2005 2012 (Pubitemid 29254858)